Europe Acute Respiratory Distress Syndrome (ARDS) Market is expected to grow with the CAGR of 9.5% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-acute-respiratory-distress-syndrome-ards-market
Europe acute respiratory distress syndrome (ARDS) market is a highly consolidated market, which includes more number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in the Europe acute respiratory distress syndrome (ARDS) market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This helped companies to maximize the sales with enhanced product portfolio.
For instance,
Gilead Sciences Inc. is the dominating player in the Europe acute respiratory distress syndrome (ARDS) market. The other key players existing in the market includes Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited., LivaNova PLC, Gilead Sciences, Inc., Fresenius SE & Co. KGaA, Armstrong Medical, Smiths Medical, ResMed, ALung Technologies, Inc., Medtronic, F. Hoffmann-La Roche Ltd, Hamilton Medical, nice Neotech Medical Systems Pvt. Ltd., Pfizer Inc., WEINMANN Emergency Medical Technology GmbH + Co. KG, NIPRO, Terumo Medical Corporation, Getinge AB., EUROSETS and among others.
Gilead Sciences Inc. is headquartered in California, U.S. and was founded in the year 1987. The company focuses on discovering and developing therapeutics for people with life-threatening diseases. Some of the product categories of the market include HIV/AIDS, COVID-19, Liver Diseases, Hematology/Oncology, Cardiovascular Inflammation/Respiratory, Other Medicines out of which nflammation/Respiratory is the market focused category.
For instance,
The company has wide presence across Europe, Asia-Pacific, North America. In addition, company also generate its revenue from various subsidiaries such as Asegua Therapeutics LLC (U.S.), Forty Seven,Inc.(U.S.), Forty Seven Holdings,LLC.(U.S.), Gilead Alberta, LLC (U.S.), Gilead Apollo, LLC.(U.S.), Gilead Biopharmaceutics US LLC (U.S.).
Terumo Corporation
Terumo Corporation is headquartered in Japan and was founded in 1921. The company focuses on giving large portfolio medical products for clinical practices. Some of the product categories of the market include Terumo Interventional Systems, Neurovascular Division, Cardiovascular Division, Vascular Graft Division out of which Cardiovascular Division is the market focused category.
For instance,
The company has wide presence across EMEA, Greater China, Asia, U.S. In addition, company also generate its revenue from various subsidiaries such as Terumo BCT, Inc.(U.S.), MicroVention, Inc.(U.S.), Terumo Aortic Limited (U.K.), Terumo (Thailand) Co.,Ltd.(Thailand), Terumo Penpol (India).
Getinge AB.
Getinge AB is headquartered in Gothenburg, Sweden and was founded in 1904. The company focuses on providing hospitals and life sciences institutions with various medical products and improve the clinical results. Some of the product categories of the market include Hospital, Life Sciences out of which Extracorporeal Life Support is the market focused category.
For instance,
The company has wide presence across EMEA, U.S, Asia. In addition, company also generate its revenue from various subsidiaries such as Getinge Australia Pty Ltd., (Australia), Getinge Belgium NV. (Belgium), Getinge do Brasil (Brazil), Equipamentos Medicos Ltda Maquet Colombia S.A.S. (Colombia), Getinge France SAS (France).
Europe Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
U.S. Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
North America Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
Middle East and Africa Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
Global Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Market – Industry Trends and Forecast to 2029
Gilead Sciences, Inc., Terumo Medical Corporation, and Getinge AB were Dominating the Global Acute Respiratory Distress Syndrome (ARDS) Market in 2021
Gilead Sciences, Inc., Terumo Medical Corporation, Getinge AB. are Dominating the U.S. Acute Respiratory Distress Syndrome (ARDS) Market in 2022